Navigation Links


ANTIGEN at Biology News

Novel antigen-cloning technique may boost efforts to develop a melanoma vaccine

In recent years, researchers have worked to develop a number of vaccines to help the immune system fight tumors. Cancer vaccines are not intended to prevent cancer; rather, they are used to boost immune responses to preexisting tumors. Unlike traditional chemotherapy, vaccines have relatively low toxicity and, potentially, a high degree of efficacy. To date, these vaccines have rarely been...
ANTIGEN at Biology Products

QuantiGene Plex Reagent Set for Animal/Plant Tissue from Panomics

Description:Homogenizing Solution, 18ml Proteinase K - [50ug/l] 75 l...
Company:Panomics

Mouse GM CSF ELISA construction Kit from Antigenix America Inc.

Description:Mouse GM CSF Construction Kit provides antigen affinity purified polyclonal capture and tracer antibodies, and antigen standard for development of approximately ten microplate assays....
Company:Antigenix America Inc.

Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone 1.F.1 from Abcam

Description:Mouse monoclonal [1.F.1] to Yersinia pestis F1 antigen ( Purified F1 antigen of Y. pestis vaccine strain EB....
Company:Abcam

Mouse Anti-Yersinia pestis F1 Antigen EB Strain Monoclonal Antibody, Unconjugated, Clone YPF19 from Meridian Life Science, Inc.

Description:MAb to Yersinia pestis F1 Ag. Yersinia pestis F1 Antigen EB Strain...
Company:Meridian Life Science, Inc.

Mouse Anti-Yersinia pestis F1 antigen Monoclonal Antibody, Unconjugated, Clone YPF19 from Novus Biologicals

Description:Mouse anti-Yersinia pestis F1 antigen, Monoclonal Antibody, Unconjugated ELISA: Use at an assay dependent dilution. IF: Use at an assay dependent dilution. WB: Use at an assay dependent dilution. Predicted molecular weight: 18 kDa. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user....
Company:Novus Biologicals

More>>

ANTIGEN at Biology Technology

Detection of Mutations in the Fas Antigen of Lymphoma Tumors by RT-PCR and Denaturing Gradient Gel Electrophoresis

Terry H. Landowski, Ibrahim Buyuksal, and William S. DaltonH. Lee Moffitt Cancer Center and Research Institute, University of SouthFlorida, 12902 Magnolia Drive, Tampa FL 33612 Introduction Identifying of mutations within specific genes has become an important strategy in determining the diagnosis and prognosis f...
ANTIGEN at Biology Definition

Antigenic shift

has difficulty recognizing the new influenza strain, it may be highly dangerous.<...

Antigen

, but it can be any type of molecule, even small molecules if coupled to a large carrier (<a href="/ ?q=/ Biology-Definition/ Hapten...
ANTIGEN at Biology Dictionary

Antigens

are present...

Antigenic variation

<a href="/ ?q=/ Biology-Dic...

Antigenic shift

...

Antigenic determinant

com...

Antigen

<A h...
ANTIGEN at Medicine News

Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time

Researchers from the department of urology in a hospital in Switzerland who investigated whether chemotherapeutic response to hormone-refractory prostate cancer could be measured via changes in prostate-specific antigen (PSA) found that prostate cancer doubling time may be an auxiliary marker of response to chemotherapy// in patients with hormone refractory prostate cancer. The study...

Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine

Antigenics Pharmaceuticals is to start its Phase III cancer vaccine trial against Melanoma which is a type of skin cancer. Oncophage is the new skin cancer vaccine developed by Antigenics.// The vaccine trial of Oncophage which was conducted in 322 patients failed to meet the required statistically significance results compared to prolongation in survival and the vaccine was not shown to have any...

Challenges in Prostate Cancer Screening by Prostate Cancer Antigen

Screening for prostate cancer using prostate specific antigen (PSA) testing continues to be problematic. Even though it is unproven whether population-wide screening with PSA can reduce death, illness or disability from prostate cancer, testing has become common in North America. A recent nation-wide survey indicates almost half of Canadian men over 50 years old are tested during thei...
ANTIGEN at Medicine Products

ENA Screen EIA Auto-Immune Markers 012-MDKES1 Extractable Nuclear Antigens

Description:ENA Screen EIA Auto-Immune Markers 012-MDKES1 Extractable Nuclear Antigens...
Company:ALPCO Diagnostics

Kallestad ENA Screen (six antigens per well),

Description:The ANA and ENA assays can be used to screen out patients negative for antinuclear antibodies, which are associated with various systemic rheumatic diseases such as Systemic lupus erythematosus (Lupus), Sjgren's syndrome, mixed connective tissue disease, progressive systemic sclerosis, scleroderma, polymyositis, dermatomyositis, and Raynaud's phenomenon. They can also be used in conjunction with...
Company:Bio-Rad Laboratories

Total Prostate Specific Antigen

Description:The Total PSA method for Dimension integrated chemistry systems with heterogeneous immunoassay module is an in vitro diagnostic test intended to quantitatively measure total prostate specific antigen (TPSA) in human serum or plasma. It is used as an aid in the detection of prostate cancer and in the management of prostate cancer patients....
Company:Dade Behring, Inc.

PSA Screen (Prostate Specific Antigen)

Description:This is a self-collected laboratory analysis that measures a substance produced by the prostate gland called Prostate Specific Antigen (PSA). Annual PSA testing is a safe and effective aid in the detection of prostate disease such as prostate cancer. One BIOSAFE Collection Kit, return postage to the Lab, test analysis by BIOSAFE's CLIA Certified Laboratory, and review of results by a licensed He...
Company:BioSafe Laboratories

EZ-PSA One-Step Prostate Specific Antigen (PSA) Test

Description:EZ-PSA is a one-step immunoassay for the rapid, qualitative determination of human Prostate Specific Antigen (PSA) in whole blood. The test is intended for professional use as an aid in the diagnosis of prostate cancer....
Company:Biomerica

More>>

ANTIGEN at Medicine Technology

Fast, Accurate Influenza A/B Antigen Detection

According to CDC data, influenza infections in this country cause more than 114,000 hospitalizations and 36,000 deaths annually. Among healthy adults, bronchitis and pneumonia are the most common complications. Together, influenza and pneumonia are the sixth leading cause of death in the United States. Influenza is particularly dangerous in elderly and immunocompromised people; however, infec...

CEL-SCI'S CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals

VIENNA, Va., May 23, 2007 /PRNewswire-FirstCall/ -- CEL-SCICORPORATION announces that CEL-1000 increased the immune responseagainst H5 avian influenza antigen in combination with MAS-1, awater-in-oil adjuvant delivery system. These findings werepresented on May 23, 2007 by Dr. Daniel Zimmerman, Senior VicePresident of Research, Cellular Immunology at CEL-SCI at theAmerican Society of Mic...

Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients

WASHINGTON, May 21, 2007/PRNewswire-FirstCall/ -- Bristol-MyersSquibb Company (NYSE: BMY) today announced new data from studyETV-079, which showed that treatment with Baraclude (entecavir)demonstrated greater viral load reduction than adefovir at 48 weeks-- a result that was also seen at weeks 12 (primary endpoint) and24. These data from an open-label, randomized viral kinetics studyof 6...

CEL-SCI's Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals

VIENNA, Va., May 01, 2007 /PRNewswire-FirstCall/ -- CEL-SCICORPORATION announces that CEL-1000 alone increased the immuneresponse against hepatitis B antigen, and that the combination ofCEL-1000 with MAS-1, a proprietary water-in-oil adjuvant deliverysystem owned by Mercia Pharma, induced highly significant increasesin specific anti-HBV (hepatitis B virus) antibodies. These findingswere...
ANTIGEN at Medicine Dictionary
Other TagsBiodieselUpdateUpdateUpdateExperienceExperienceExperienceExperienceTears
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
(Date:9/4/2008)...rship between Syracuse University and the Serum In...fe-saving vaccines for children living in some of ...titute recently awarded $250,000 to a team of SU r...r of chemistry in the College of Arts and Sciences... rotavirus, a severe form of diarrhea that affects...
(Date:9/4/2008).... -- A team including researchers at the HudsonAlp...h colleagues from a number of other organizations,...ic variation in the brain cancer glioblastoma. The...las (TCGA) research network, a collaborative effor...National Human Genome Research Institute of the Na...
(Date:9/4/2008)...ING HARBOR, N.Y. (Sept. 4, 2008) A variety of or...lshave biological rhythms, where the timing and du...rally adjusted to allow them to adapt and survive,... In recent years, significant advances have been m...thms and how they translate into modifications in ...
(Date:9/4/2008)... research from Rhode Island Hospital found that ob...ribute to mild neurodegeneration with features com... to show that obesity can cause neurodegeneration.... Disease Volume 15:1 (September 2008) . , In a...e la Monte, MD, MPH, of Rhode Island Hospital, uti...
Breaking Biology News(10 mins):Syracuse University partners with Serum Institute of India to develop vaccines for children 2Syracuse University partners with Serum Institute of India to develop vaccines for children 3Syracuse University partners with Serum Institute of India to develop vaccines for children 4Collaboration between researchers yields more comprehensive portrait of brain cancer 2Interdisciplinary volume on biological rhythms serves as both primer and in-depth resource 2Drug for anemic cancer patients raises risk of death 12809 1Drug for anemic cancer patients raises risk of death 12809 2Drug for anemic cancer patients raises risk of death 12809 3Correction 3A Therapist to Young Hollywood Says Male Stars in Psychological Trouble Get a Media Pass as Compared to Female Stars 12804 1Hologic to Present at the Raymond James 26 Associates 29th Annual Institutional Investors Conference 12800 1Hologic to Present at the Raymond James 26 Associates 29th Annual Institutional Investors Conference 12800 2CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 1CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 2CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 3CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 4CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 5CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 6CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 7CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results 3534 8
Other Contentsquarantinequarantinepyridoxineprogressiveprogressiveprogressiveprogressiveprogressiveprogressiveprogressiveprogressiverapidlyrapidlyrapidlyrapidlyrapidlyrapidlyrapidlyrapidlyrapidlyquadriceps